期刊文献+

盐酸氢吗啡酮联合丙泊酚在无痛人流手术中的效果分析 被引量:2

下载PDF
导出
摘要 目的:探讨盐酸氢吗啡酮联合丙泊酚在无痛人流手术中的效果。方法:选取在我院进行自愿流产手术终止妊娠的孕早期女性400例,按照随机数字法分为两组,对照组采用丙泊酚进行麻醉,实验组在对照组的基础上联合盐酸氢吗啡酮进行麻醉。对两组的麻醉效果以及不良反应进行比较。结果:实验组患者用药至失去意识时间为(33.25±2.7)s、苏醒时间为(9.1±1.2)s、追加丙泊酚比例为24%、不良反应发生率为28%,均显著优于对照组,差异有统计学意义(P<0.05)。结论:盐酸氢吗啡酮联合丙泊酚麻醉在无痛人流手术中的效果明显,失去意识时间长,苏醒时间短,不良反应发生率低,值得临床广泛使用。
作者 张健
出处 《牡丹江医学院学报》 2014年第6期77-78,共2页 Journal of Mudanjiang Medical University
  • 相关文献

参考文献8

二级参考文献62

  • 1李小燕,陈笑艳,徐静华,金鑫,钟大放.LC-MS/MS法测定比格犬血浆中氢吗啡酮[J].质谱学报,2003,24(z1):89-90. 被引量:2
  • 2郑清民,李师阳,肖全胜,姚伟瑜,房小斌.雷米芬太尼和丙泊酚复合麻醉用于人工流产的观察[J].临床麻醉学杂志,2005,21(1):64-64. 被引量:22
  • 3柴芳,张炳熙.肥胖病人与麻醉[J].医学研究杂志,2006,35(9):93-94. 被引量:13
  • 4张学俊,张洪全,张彦伟,高秀娟,张宗旺.氯诺昔康对剖宫产术后宫缩痛的抑制作用[J].山东医药,2006,46(30):49-49. 被引量:4
  • 5陈伯銮.临床药理麻醉学.北京:人民卫生出版社,2000:297-301.
  • 6Murray A, Hagen NA.Hydromorphone [J]. J Pain Sympt Manage, 2005, 29(3): 5-66.
  • 7Lee JW, Pedersen JE, Moravetz TL, et al. Shepard. Sensitive and specific radioimmunoassays for opiates using commercially available materials. Ⅰ: Methods for the determinations of morphine and hydromorphone[J]. J Pharm Sci, 1991, 80(3): 284-8.
  • 8Wetzelsberger N, Lucker PW, Erking W. High-pressure liquid chromatographic method for the determination of hydromorphone in human plasma with electrochemical detection[J]. A rzneimittelforschung, 1986, 36(11): 1707-10.
  • 9Bouquillon AI, Freeman D, Moulin DE. Simultaneous solid-phase extraction and chromatographic analysis of morphine and hydromorphone in plasma by high-performance liquid chromatography with electrochemical detection[J]. J. Chromatogr, 1992, 577(2): 354-7.
  • 10Weng ND, Jiang XY, Newland K, et al. Development and validation of a sensitive method for hydromorphone in human plasma by normal phase liquid chromatography-tandem mass spectrometry [J]. J Pharm Biomed Anal, 2000, 23(4): 697-704.

共引文献41

同被引文献38

  • 1Felden L,Walter C,Harder S,et al.Comparative clinical effects of hydro- morphone and morphine:a meta-analysis[J].BrJ Anaesth,2011,107(3):319-328.
  • 2Chang AK,Bijur PE,Baccelieri A,et al.Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute,severe pain:a prospective,randomized,double-blind clinical trial[J].AmJ Geriatr Pharmacother,2009,7(1):1-10.
  • 3Kumar P,Sunkaraneni S,Sirohi S,et al.Hydromorphone efficacy and treat- ment protocol impact on tolerance and mu-opioid receptor regulation[J]. Eur J Pharmacol,2008,597(1/2/3):39-45.
  • 4Turgeon J,G,Qning R,Sathyan G,et al.The pharmacokinetics of a long- acting OROS hydromorphone formulation[J].Expert Opin Drug Deliv,2010,7(1):137-144.
  • 5Jeleazcov C,Saari TI,Ihmsen H,et al.Population pharmacokinetic mo- deling of hydromorphone in cardiac surgery patients during postoperative pain therapy[J].Anesthesiology,2014,120(2):378-391.
  • 6Abrishamkar S,Eshraghi N,Feizi A,et al.Analgesic effects of ketamine infusion on postoperative pain after fusion and instrumentation of the lumbar spine:a prospective randomized clinical trial[J].Med Arh,2012,66(2):107-110.
  • 7Lee SH,Lee CJ,Kim TH,et al.Novel Use of Hydromorphone as a Pretreat- ment Agent:A Double-blind,Randomized,Controlled Study in Adult Korean Surgical Patients[J].Curr Ther Res Clin Exp,2011,72(1):36-48.
  • 8Chang AK,Bijur PE,Napolitano A,et al.Two milligrams i.v.hydromor- phone is efficacious for treating pain but is associated with oxygen desatu- ration[J].J Opioid Manag,2009,5(2):75-80.
  • 9Chang AK,Bijur PE,Davitt M,et al.Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with tra- ditional physician-driven management of emergency department patients with acute severe pain[J],Ann Emerg Med,2009,54(4):561-567.
  • 10Hanna M,Thipphawong J.A randomized,double-blind comparison of OROS(R)hydromorphone and controlled-release morphine for the con- trol of chronic cancer pain[J].BMC PaIl G are,2008,7:17.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部